Congress trades
RVNC Revance Therapeutics, Inc.
Members of Congress who traded or hold Revance Therapeutics, Inc., from their STOCK Act disclosures. None of the featured 13F managers hold it, so this page covers Congress only.
- 1 members traded it since Oct 4, 2023
- 1 / 0 buys / sales
- 1 held it at year end (2023)
- Oct 4, 2023 latest trade
Who holds it
Each member's latest annual report · value at year end, in the range disclosed
-
Thomas R. Carper
$1K–$15K
Trades
1 trade since Oct 4, 2023 · newest filings first
-
RVNCRevance Therapeutics, Inc.Buy$1K–$15KTraded Oct 4, 2023Filed Nov 2, 2023 29d
No trades match these filters.
Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. All Congress trades · How we read these reports.